Compound details
Mevalonic acid
| Compound ID | CDAMM02068 |
|---|---|
| Common name | Mevalonic acid | IUPAC name | 3,5-dihydroxy-3-methylpentanoic acid |
| Molecular formula | C6H12O4 |
| Retention time | 0.55 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 149.081 | Theoretical mz | 149.081 |
| Error | 1.85 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.1218 |
| Inchi key | KJTLQQUUPVSXIM-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(O)CC(O)(C)CCO |
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SwissTargetPrediction |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SwissTargetPrediction |
| Q86YT5 | SLC13A5 | Solute carrier family 13 member 5 | T81547 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |